Work

Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A

Year: 2008

Type: article

Study design: Clinical Trial

Source: Vaccine

DOI: 10.1016/j.vaccine.2008.04.042

Authors: Claribel P. Taylor, Sanjeev Tummala, Deborah Molrine, Lisa Davidson, Richard J. Farrell, Anthony Lembo, Patricia L. Hibberd, Israel Lowy, Ciaran P. Kelly

Institutions: Beth Israel Deaconess Medical Center, University of Massachusetts Chan Medical School, Tufts Medical Center, Bloomsbury Publishing (United Kingdom)

Language: English

Topic: Clostridium difficile and Clostridium perfringens research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources

Awards: G1521345354, G2446437262, General Clinical Research Center, G3028157465, GENERAL CLINICAL RESEARCH CENTER, SCHOLARS IN CLINICAL SCIENCE PROGRAM, Research Training in Gastroenterology, G5945296186, Immune Response to Clostridium difficile

OpenAlex ID: W2049511418

FWCI: 2.8

Cites: 46

Cited by: 52

Related to: 10